Foto: Uni-Klinikum Erlangen
FAU/Celina Henning


Strengthening the immune response at the location where the virus enters the body. A team led by Prof. Dr. Klaus Überla and Prof. Dr. Matthias Tenbusch at the Institute of Clinical and Molecular Virology at FAU is currently conducting research into a vaccine that is administered as a nose or mouth spray and forms local antibodies in the mucous membranes. The project has received 280,000 euros of further funding.